DEC 11, 2017 07:46 AM PST

First-Ever Gene Therapy for Babies with "Bubble Boy" Disease

WRITTEN BY: Kara Marker

There is a genetic disorder affecting the immune system so severely that its patients often require protective isolation, hence the disease’s nickname: “Bubble Boy Disease.” Scientists know this disease as X-linked severe combined immunodeficiency disorder (XSCID). From the St. Jude Children’s Research Hospital, scientists conduct the first-ever clinical trial in infants with XSCID to test the effectiveness of the newest gene therapy approach to treating the disease.

XSCID gene therapy has been well tolerated and effective for infants as young as 2 months old. Credit: St. Jude Children's Research Hospital

Babies born with XSCID have a mutation in the IL2RG gene, which is normally responsible for making a protein called the “common gamma chain.” Without this protein, the immune system’s function is critically impaired, as immune cells like T cells, B cells, and natural killer cells fail to effectively grow and mature. XCID affects a disproportionate amount of boys, and untreated individuals die of infections without an immune system for protection.

Current treatment for XSCID relies on something that more than 80 percent of XSCID patients don’t even have: a tissue-matched sibling donor for transplantation. Incomplete genetic matches such as parents can act as donors, but the transplantation is fraught with complications and the procedure is much less likely to effectively rejuvenate the immune system.

The new gene therapy from St. Jude provides an alternative to a tissue-matched sibling donor. Researchers instead developed a lentiviral vector, which carries a normal copy of the IL2RG gene and delivers it into the hematopoietic stem cells of patients with XSCID. This treatment also contains certain features to promote safety and effectiveness.

The treatment process involves remove bone marrow so the hematopoietic stem cells can incubate with the lentiviral vector carrying normal IL2RG. Afterward, the stem cells are returned via transfusion.

The clinical trial at St. Jude enrolled seven patients between the ages of 2 and 13 months old. Four months after treatment, five patients had developed immune systems strong enough where they no longer needed protected isolation, containing near normal levels of T, B, and natural killer cells of the immune system, and nearly all were carrying the normal version of the IL2RG gene.

"These results are an exciting early indication that this gene therapy is well tolerated and effective in infants as young as 2 months old with this devastating inherited immune disorder," explained St. Jude’s Ewelina Mamcarz, MD.

Mamcarz’s co-study leader, Brian Sorrentino, MD, agrees, saying that the findings “reinforce hope that gene therapy will prove to be safe and effective at restoring immune function early in life.”

Sources: Genetics Home Reference, St. Jude Children’s Research Hospital

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 01, 2018
Videos
AUG 01, 2018
Award-winning Images of Organoids From the Koch Institute
Every year, the Koch Institute at MIT shares some of the most stunning images produced at the research facility....
AUG 12, 2018
Genetics & Genomics
AUG 12, 2018
Bringing Genetics Research to the Developing World
Researchers want to ensure that technology is distributed equitably, to benefit everyone....
AUG 19, 2018
Technology
AUG 19, 2018
CRISPR Technology Seeks To Eliminate Genetic Diseases
Researchers at the University of Illinois have adapted to new CRISPR gene-editing technology that causes the cell's internal machinery to skip over a s...
AUG 27, 2018
Genetics & Genomics
AUG 27, 2018
A Better Way to Classify Bacteria
The classification of organisms into groups, taxonomy, has taken an important step forward....
SEP 02, 2018
Cell & Molecular Biology
SEP 02, 2018
Cancer Cell Lines can Evolve in the Lab
New research shows that scientists have to take steps to verify the identity of the cell lines they grow....
SEP 15, 2018
Genetics & Genomics
SEP 15, 2018
Data-based Health Management Tool for Aortic Aneurysm
This tool might be extrapolated for many other disorders, and may free patients from repeated doctor visits....
Loading Comments...